AIP
AGN

Almanack Investment Partners’s Allergan plc AGN Stock Holding History

Almanack Investment Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9,032
Closed -$1.6M – 293
2020
Q1 		$1.6M Buy
+9,032
New +$1.7M 0.34% 43

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Almanack Investment Partners's AGN Position: Q2 2020 in Review

Almanack Investment Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 9,032 shares — an estimated $1.6M sold.

Almanack Investment Partners first reported a position in AGN in Q1 2020 and held it in 1 quarter. The position peaked at $1.6M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Almanack Investment Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Almanack Investment Partners sold 9,032 Allergan plc shares in Q2 2020, an estimated $1.6M.
  • Almanack Investment Partners first reported a position in Allergan plc in Q1 2020 and held it in 1 quarter.
  • Almanack Investment Partners's Allergan plc position peaked at $1.6M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Almanack Investment Partners's 13F filing for Q2 2020, filed 10 Aug 2020.